Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BioAmber Inc. | 40,000 | reported | 15 Aug 2017 | tx 12+218,916 |
| CLARIENT, INC | 30,400 | reported | 24 Nov 2008 | tx 11+530,500 |
| SAFEGUARD SCIENTIFICS INC | 26,100 | reported | 15 Jun 2007 | tx 6+1,526,100 |
| Anika Therapeutics, Inc. | 12,125 | reported | 16 Jun 2021 | tx 42+65,375−50,400 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jun 2021 | GRANT_AWARD | Anika Therapeutics, Inc. | 4,172 | 0.00 USD | |
| 12 May 2021 | SALE | Anika Therapeutics, Inc. | 2,000 | 42.60 USD | |
| 10 Nov 2020 | SALE | Anika Therapeutics, Inc. | 3,446 | 36.77 USD | |
| 26 Feb 2020 | SALE | Anika Therapeutics, Inc. | 2,700 | 42.68 USD | |
| 25 Feb 2020 | GRANT_AWARD | Anika Therapeutics, Inc. | 4,107 | 0.00 USD | |
| 29 Jul 2019 | SALE | Anika Therapeutics, Inc. | 3,000 | 55.44 USD | |
| 26 Feb 2019 | GRANT_AWARD | Anika Therapeutics, Inc. | 3,842 | 0.00 USD | |
| 26 Feb 2019 | SALE | Anika Therapeutics, Inc. | 4,000 | 33.06 USD | |
| 24 Jan 2018 | GRANT_AWARD | Anika Therapeutics, Inc. | 1,626 | 0.00 USD | |
| 15 Aug 2017 | PURCHASE | BioAmber Inc. | 40,000 | — | |
| 15 Aug 2017 | PURCHASE | BioAmber Inc. | 40,000 | — | derivfirst after silence |
| 15 Aug 2017 | PURCHASE | BioAmber Inc. | 13,333 | — | |
| 15 Aug 2017 | PURCHASE | BioAmber Inc. | 13,333 | — | deriv |
| 11 May 2017 | GRANT_AWARD | BioAmber Inc. | 36,000 | 0.00 USD | deriv |
| 22 Feb 2017 | SALE | Anika Therapeutics, Inc. | 2,635 | 49.08 USD | |
| 27 Jan 2017 | GRANT_AWARD | Anika Therapeutics, Inc. | 1,994 | 0.00 USD | |
| 19 May 2016 | GRANT_AWARD | BioAmber Inc. | 24,000 | 0.00 USD | deriv |
| 25 Feb 2016 | SALE | Anika Therapeutics, Inc. | 2,695 | 43.62 USD | |
| 04 Feb 2016 | GRANT_AWARD | Anika Therapeutics, Inc. | 2,361 | 0.00 USD | |
| 10 Aug 2015 | PURCHASE | BioAmber Inc. | 1,500 | 6.71 USD | first after silence |
| 31 Jul 2015 | SALE | Anika Therapeutics, Inc. | 1,018 | 37.76 USD | |
| 30 Jul 2015 | TAX_WITHHOLDING | Anika Therapeutics, Inc. | 522 | 36.51 USD | |
| 30 Jul 2015 | SALE | Anika Therapeutics, Inc. | 690 | 37.39 USD | |
| 30 Jul 2015 | EXERCISE | Anika Therapeutics, Inc. | 1,540 | 12.36 USD | |
| 30 Jul 2015 | EXERCISE | Anika Therapeutics, Inc. | 1,540 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 15 Aug 2017.